Bioline Rx reported $13.62M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Arca Biopharma USD 22.97M 6.34M Jun/2026
Bio Path USD 9.15M 468K Mar/2026
Bioline Rx USD 13.62M 1.5M Mar/2026
Capricor Therapeutics USD 32.96M 676K Jun/2026